bn 52211 has been researched along with concanavalin a in 1 studies
| Studies (bn 52211) | Trials (bn 52211) | Recent Studies (post-2010) (bn 52211) | Studies (concanavalin a) | Trials (concanavalin a) | Recent Studies (post-2010) (concanavalin a) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 17,959 | 82 | 1,337 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braquet, P; Broquet, C; Chaumeron, S; Coulomb, H; Maisonnet, T; Mencia-Huerta, JM; Pignol, B; Vandamme, B | 1 |
1 other study(ies) available for bn 52211 and concanavalin a
| Article | Year |
|---|---|
Immunomodulatory activity of two new aza alkyl phospholipid antineoplastic drugs.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cell Division; Cell Line; Concanavalin A; Humans; Interferon-gamma; Interleukin-1; Interleukin-6; Killer Cells, Natural; Lymphocytes; Lysophospholipids; Monocytes; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 1992 |